Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$4.14 - $22.9 $72,926 - $403,383
-17,615 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$3.84 - $6.0 $36,038 - $56,310
-9,385 Reduced 34.76%
17,615 $80,000
Q1 2021

May 14, 2021

BUY
$4.39 - $6.53 $118,529 - $176,310
27,000 New
27,000 $127,000

Others Institutions Holding VRPX

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0

About Virpax Pharmaceuticals, Inc.


  • Ticker VRPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,714,600
  • Market Cap $7.97M
  • Description
  • Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical no...
More about VRPX
Track This Portfolio

Track Saltoro Capital, LP Portfolio

Follow Saltoro Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saltoro Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Saltoro Capital, LP with notifications on news.